Evaluation of the clinical efficacy of Qinghuatanshi Decoction in the treatment of Plasma cell mastitis during perioperative period
- Conditions
- Plasma cell mastitis
- Registration Number
- ITMCTR2100005055
- Lead Sponsor
- Shuguang Hospital Affiliated to Shanghai University of traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- Not specified
1. Admission surgery and the pathological diagnosis is consistent with the diagnosis in granulomatous mastitis;
2. Female patients who meet the criteria of phlegm-dampness syndrome differentiation of acne mammary carbuncle;
3. The tumor range is more than or equal to 2 quadrants;
4. Age between 18 and 65 years old;
5. Non-pregnant, lactating women and no other mastitis;
6. Patients or their family members signed the informed consent.
1. Patients with serious primary diseases such as heart, cerebrovascular, liver, kidney and hematopoietic system;
2. Combined with a history of mental illness and malignant tumor;
3. Diagnosis of systemic lupus erythematosus, rheumatic diseases or other known autoimmune diseases;
4. There is a history of surgical treatment and/or oral corticosteroid treatment before enrollment.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method total efficiency;
- Secondary Outcome Measures
Name Time Method The Breast-Q scale;Total effective rate;mRNA differential gene expression profile;Pain VAS score;